Medivir AB (publ) (STO:MVIR)
Sweden · Delayed Price · Currency is SEK 1.936
-0.042 (-2.12%)
Sep 2, 2026, 5:29 PM CET
Medivir AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 8.71 | 8.51 | 3.48 | 7.63 | 4.41 | 25.54 |
Other Revenue | - | - | - | - | - | 6.86 |
| 8.71 | 8.51 | 3.48 | 7.63 | 4.41 | 32.39 | |
Revenue Growth | 118.52% | 144.14% | -54.36% | 73.16% | -86.39% | 58.56% |
Cost of Revenue | 40.61 | 41.41 | 101.27 | 68.87 | 69.08 | 73.28 |
Gross Profit | -31.91 | -32.91 | -97.79 | -61.23 | -64.67 | -40.88 |
Selling, General & Admin | 22.76 | 27.06 | 27.16 | 27.37 | 20.74 | 21.42 |
Other Operating Expenses | 0.19 | 0.49 | 0.39 | 1.41 | 0.63 | -0.49 |
Operating Expenses | 54.66 | 60.06 | 30.28 | 31.52 | 23.94 | 23.52 |
Operating Income | -86.57 | -92.97 | -128.07 | -92.75 | -88.61 | -64.4 |
Interest Expense | -2.31 | -2.41 | -0.78 | -0.91 | -0.93 | -0.95 |
Interest & Investment Income | 1.14 | 0.04 | 0.07 | 0.03 | 0.01 | - |
Currency Exchange Gain (Loss) | 0.37 | 0.37 | 0.73 | 1.34 | 1.22 | 1.6 |
Other Non Operating Income (Expenses) | -0.5 | - | - | 0 | - | 0 |
EBT Excluding Unusual Items | -87.87 | -94.97 | -128.05 | -92.3 | -88.31 | -63.75 |
Gain (Loss) on Sale of Investments | 0.57 | 0.57 | 4.73 | 2.98 | -0.49 | 0.49 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.04 | 0.68 |
Pretax Income | -87.3 | -94.4 | -123.32 | -89.32 | -88.77 | -62.58 |
Income Tax Expense | - | - | - | - | - | 0.55 |
Earnings From Continuing Operations | -87.3 | -94.4 | -123.32 | -89.32 | -88.77 | -63.13 |
Net Income | -87.3 | -94.4 | -123.32 | -89.32 | -88.77 | -63.13 |
Net Income to Common | -87.3 | -94.4 | -123.32 | -89.32 | -88.77 | -63.13 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 348 | 143 | 114 | 60 | 56 | 53 |
Shares Outstanding (Diluted) | 348 | 143 | 114 | 60 | 56 | 53 |
Shares Change | 203.20% | 25.08% | 88.71% | 8.44% | 5.53% | 117.45% |
EPS (Basic) | -0.25 | -0.66 | -1.08 | -1.48 | -1.59 | -1.20 |
EPS (Diluted) | -0.26 | -0.66 | -1.08 | -1.48 | -1.59 | -1.20 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -51.65 | -73.35 | -124.19 | -59.67 | -102.2 | -48.73 |
Free Cash Flow Per Share | -0.15 | -0.51 | -1.09 | -0.99 | -1.83 | -0.92 |
Gross Margin | - | - | - | - | - | -126.20% |
Operating Margin | -994.36% | -1092.98% | -3675.95% | -1215.16% | -2010.16% | -198.80% |
Profit Margin | -1002.76% | -1109.81% | -3539.52% | -1170.21% | -2013.73% | -194.87% |
Free Cash Flow Margin | -593.25% | -862.31% | -3564.61% | -781.67% | -2318.56% | -150.44% |
EBITDA | -87.28 | -92.88 | -127.94 | -92.62 | -88.4 | -64.08 |
EBITDA Margin | - | - | - | - | - | -197.81% |
D&A For EBITDA | -0.72 | 0.09 | 0.13 | 0.14 | 0.2 | 0.32 |
EBIT | -86.57 | -92.97 | -128.07 | -92.75 | -88.61 | -64.4 |
EBIT Margin | - | - | - | - | - | -198.80% |
Revenue as Reported | 8.78 | 8.88 | 4.46 | 9 | 6.23 | 35.74 |